Olawunmi Oyedeji | Oncology | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Olawunmi Oyedeji
The Christie NHS Foundation Trust

                          Olawunmi Oyedeji
Affiliation The Christie NHS Foundation Trust
Country United Kingdom
Scopus ID 58803277000
Documents 2
Citations 2
h-index 2
Subject Area Oncology
Event Global Diseases Research Awards
ORCID 0009-0008-0626-3422

Olawunmi Oyedeji is a researcher affiliated with The Christie NHS Foundation Trust, United Kingdom, whose academic activities contribute to the field of oncology research. The Innovative Research Award recognizes researchers demonstrating valuable contributions through scientific investigation, clinical advancement, and knowledge development within their respective disciplines. [1]

Abstract

The Innovative Research Award highlights academic excellence and meaningful contributions in oncology research. Olawunmi Oyedeji, affiliated with The Christie NHS Foundation Trust, United Kingdom, represents emerging research activities focused on advancing healthcare knowledge and improving scientific understanding. With documented publications, citations, and research engagement indexed through Scopus, the researcher demonstrates participation in scholarly communication. The award recognizes dedication toward innovative approaches, evidence-based practices, and contributions supporting progress in global disease research and clinical advancement. [1]

Keywords

Oncology Research, Clinical Research, Innovative Research Award, Cancer Research, Healthcare Innovation

Introduction

Oncology research plays an important role in understanding cancer biology, improving diagnosis, and developing effective therapeutic strategies. Researchers working within clinical and academic institutions contribute essential evidence that supports improvements in patient care and healthcare systems. [2]

Research Profile

Olawunmi Oyedeji is associated with The Christie NHS Foundation Trust, a leading healthcare institution in the United Kingdom. The research profile includes two indexed documents, two citations, and an h-index of two according to available Scopus information. [1]

Research Contributions

The researcher’s contributions are positioned within oncology and healthcare research. Scientific contributions in this area support better understanding of diseases, treatment approaches, clinical methodologies, and evidence-based medical practices. Such efforts strengthen collaborative research environments and promote advancement in cancer-related knowledge. [2]

Publications

The researcher has published scholarly documents indexed within Scopus databases. These publications contribute to academic discussions in oncology and related healthcare disciplines. Research outputs provide opportunities for knowledge exchange and future scientific collaboration among international researchers. [3]

Research Impact

Research impact is reflected through scholarly visibility, citation activity, and contribution to scientific literature. The available metrics indicate participation in academic research communication and demonstrate the importance of continued investigation within oncology and clinical sciences. [4]

Award Suitability

The Innovative Research Award recognizes researchers who demonstrate commitment toward scientific advancement and meaningful research activities. Based on the researcher’s oncology-focused profile, institutional affiliation, and academic contributions, Olawunmi Oyedeji represents a suitable candidate for recognition within the Global Diseases Research Awards framework. [4]

Conclusion

Olawunmi Oyedeji’s research profile demonstrates involvement in oncology-related scientific activities through institutional association, publications, and academic indexing. The Innovative Research Award acknowledges continued efforts toward research development and contributions supporting healthcare innovation and global scientific progress.

External Links

References

  1. Elsevier. (n.d.). Scopus author details: Olawunmi Oyedeji, Author ID 58803277000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58803277000
  2. Global Diseases Research Awards. (n.d.). Innovative Research Award Information.
    https://globaldiseases.org/
  3. Oisakede, E. O., Oyedeji, O. O., Olawuyi, O. F., Alabi, J. O., Daniel, R. I. A., & Olawade, D. B. (2026). Nanoparticle-mediated cardiotoxicity and nanomedicine interventions in cancer treatment. Nano TransMed, 5, Article 100113.
    https://doi.org/10.1016/j.ntm.2026.100113
  4. Oyedeji, O. O., & Oisakede, E. O. (2026). Radiation-induced rhinosinusitis after treatment of nasopharyngeal and selected sinonasal cancers: A narrative review. Sinusitis, 10(1), Article 100015.
    https://doi.org/10.3390/sinusitis10010015

Hsuan Liu | Cancer Genomics | Research Excellence Award

Published on by Global Diseases Research

Prof. Dr . Hsuan Liu | Cancer Genomics | Research Excellence Award

Chang Gung University | Taiwan

Dr. Hsuan Liu is a distinguished researcher at Chang Gung University, recognized for impactful contributions across interdisciplinary scientific domains. With 58 publications and 1,736 citing documents, Dr. Liu’s work demonstrates strong scholarly influence and sustained research productivity. An h-index of 21 reflects both consistency and depth of academic impact. Collaborating with more than 300 co-authors, Dr. Liu contributes to advancing knowledge through extensive international and cross-disciplinary partnerships. Their research outputs not only strengthen scientific understanding but also support societal progress by informing innovative solutions, enhancing academic discourse, and contributing to global research excellence.

Citation Metrics (Scopus)

1,781
1,000
500
250
0

Citations

1,781

Documents

58

h-index

21

Citations

Documents

h-index


View Scopus ProfileView ORCID Profile

 

Top 5 Featured Publications

Elisabeth Spenard | Gynecologic Oncology | Best Researcher Award

Published on by Global Diseases Research

Assist. Prof. Dr. Elisabeth Spenard | Gynecologic Oncology | Best Researcher Award 

MD | Laval University | Canada

Dr. Elisabeth Spénard, MD, MSc, FRCSC, is a highly accomplished Gynecologic Oncologist and Clinical Teaching Associate at Université Laval, where she also serves as Academic Director, Co-Research Director, and Quality Improvement Lead in the Division of Gynecologic Oncology. She holds active staff appointments in Gynecologic Oncology at Hôtel-Dieu de Québec and has been an Assistant Professor at the Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto, where she supervises Master’s students in the Quality Improvement and Patient Safety (QIPS) program. Dr. Spénard completed her residency in Obstetrics and Gynecology at the University of Montreal, a fellowship in Gynecologic Oncology at the University of Toronto, and a Master of Science in QIPS, equipping her with strong expertise in patient-centered care, surgical oncology, and clinical research. Her professional journey is marked by leadership roles in national and institutional committees, including co-leading the ERAS Gynecology Oncology Committee with Quebec’s Ministry of Health and serving as a reviewer and judge for ovarian cancer research awards. She has earned multiple awards, such as the Bruce Galloway Trainee Award, and distinctions for best oral and poster presentations from leading Canadian gynecologic oncology associations. Her research is focused on hereditary cancers, surgical innovation, and quality improvement, supported by competitive grants such as the Surgical Oncology Innovations Grant and Canadian Blood Services Accelerator Grant. With an expanding academic footprint, Dr. Spénard has authored 6  publications, cited 35 times, with an h-index of 3, underscoring her growing contributions to advancing gynecologic oncology research and education

Profile: Scopus

Featured Publication

1. Spénard, E., Lin, Y., Covens, A., Gien, L. T., Vicus, D., et al. (2025). Optimizing the screening and management of preoperative anemia prior to gynecologic oncology surgery (OPRA1): A quality improvement initiative. Gynecologic Oncology. Advance online publication.